Cofactor Genomics ImmunoPrism Immune Profiling Kit

Cofactor Genomics launched the RNA-based ImmunoPrism Immune Profiling kit for deriving the immune composition of tumor samples, which it said has become a valuable indicator of response to immunotherapies and cancer drugs in development. The kit provides labs access to the same kit Cofactor uses to prep, sequence, and analyze against its database of machine-learing optimized immune reference expression models.